INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo LIZORP 250 mg
LIZORP 500 mg

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

SCHEDULING STATUS:
no data

PROPRIETARY NAME
(and dosage form):

LIZORP 250 mg
LIZORP 500 mg
tablet

COMPOSITION:
LIZORP 250 mg: each tablet contains ceprozil monohydrate equivalent to anhydrous
cefprozil 250 mg
LIZORP 500 mg: each tablet contains ceprozil monohydrate equivalent to anhydrous cefprozil 500 mg

ATC CLASSIFICATION:
no data

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
LIZORP 250 mg: 41/20.1.1/0586
LIZORP 500 mg: 41/20.1.1/0587

APPLICANT:
Aurobindo Pharma (Pty) Ltd

MANUFACTURER:
AUROBINDO PHARMA LIMITED, PATANCHERU MANDAL, MEDAK DISTRICK, ANDHRA PRADESH, INDA

AVAILABILITY:
no data - please check with company.

DATE OF REGISTRATION:
05 December 2013

SOURCE: Government Gazette -
STAATSKOERANT, 13 JUNIE 2014 No. 37727
NOTICE 405 OF 2014 - MEDICINES CONTROL COUNCIL

Posted: July 2014

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2014